biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BTI tweets:

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon May 16, 2023 5:25pm

70 Views

Post# 35451198

RE:RE:RE:RE:RE:BTI tweets:

beenthere, a half penny upswing on a penny stock is a 50% gain. Traders usually work on single digit gain percentages.

An active stock at 5¢ or less can make a lot of money for a trader if there is a lttle liquidity. Even a penny gain on 5¢ is a 20% gain.

There's money to be made here on Bioasis for a trader. He can make a lot more than grocery money.

I would also argue that causing people to sell stock is currently easier to do than usual with Bioasis. Deadline coming. Financial cliff on Monday. Blah blah blah.

jd

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale